Man Group
DPLO

Man Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Man Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,400
Closed -$51K – 1974
2019
Q3 		$51K Buy
+10,400
New +$58.2K ﹤0.01% 1753
2018
Q4 		– Sell
-483,565
Closed -$9.39M – 2222
2018
Q3 		$9.39M Buy
483,565
+460,083
+1,959% +$9.8M 0.03% 662
2018
Q2 		$600K Buy
+23,482
New +$548K ﹤0.01% 1760

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Man Group's DPLO Position: Q4 2019 in Review

Man Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 10,400 shares — an estimated $51K sold.

Man Group first reported a position in DPLO in Q2 2018 and held it in 3 quarters. The position peaked at $9.39M in Q3 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Man Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Man Group sold 10,400 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $51K.
  • Man Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2018 and held it in 3 quarters.
  • Man Group's DIPLOMAT PHARMACY, INC. position peaked at $9.39M in Q3 2018.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.